NewsFox News PoliticsMay 2, 2026United States
Federal Appeals Court Blocks Mail-Order Abortion Pill Mifepristone
A federal appeals court has blocked the mailing of the abortion pill mifepristone under current FDA rules, a decision that will likely lead to a Supreme Court battle over abortion access. The ruling restores a requirement for in-person medical consultation to obtain the prescription, reversing a pandemic-era change.
Read the full story at Fox News PoliticsWhy It Matters
This ruling significantly impacts access to abortion medication nationwide, potentially restricting healthcare options even in states where abortion remains legal and setting the stage for a major Supreme Court case.
Key Facts
- A federal appeals court has blocked the mailing of the abortion pill mifepristone.
- The ruling restores a requirement for women to see a medical professional for a prescription.
- The decision is expected to have a nationwide effect and may lead to a Supreme Court battle.
- The court criticized the FDA's handling of mifepristone's safety data and reporting requirements.
- The ruling sided with pro-life states seeking to enforce stricter abortion laws.
Who's Mentioned
personDavid C. Josephdollar_amount$705dateFridaypersonJoe BidenpersonKristan HawkinsorganizationGuttmacher InstituteorganizationFood and Drug Administration (FDA)date2022other705datelast monthorganization5th U.S. Circuit Court of AppealspersonTony PerkinsorganizationFamily Research Council“xes of mifepristone used for medical abortions. (Evelyn Hockstein/Reuters, File)”organizationDepartment of Health and Human ServicesotherMifepristonepersonLiz MurrillorganizationSupreme CourtotherRoe v. WadepersonLetitia JameslocationLouisianaorganizationStudents for LifeorganizationFamily Research Council